
ESC Congress - European Society of Cardiology
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to ESC Congress - European Society of Cardiology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
ESC Congress – European Society of Cardiology (ESC Congress 2026) — Buyer Research & Event Fit Analysis
Event Basics (from provided official page text)
- Event name: ESC Congress 2026
- Organizer: European Society of Cardiology (ESC)
- Official event page source: https://www.escardio.org/events/congresses/esc-congress/
- Dates: Munich mentioned, but exact dates are not present in the provided excerpt → not available in provided text
- Venue: Munich mentioned, but exact venue/campus name is not present in the provided excerpt → not available in provided text
- City & country: Munich, Germany (city stated in the provided excerpt; country implied by Munich and not explicitly stated in the excerpt) → Munich, Germany (Munich is explicitly referenced)
- Event positioning: described as “World’s Foremost Cardiology Meeting” and focused on AI’s role in cardiology, with hands-on learning and global expert engagement
1) Who attends (BUYERS / ATTENDEES)
ESC Congress is not just a physician-only academic meeting. It attracts a dense mix of decision-makers and influencers across the cardiovascular ecosystem. For buyer-focused list building, the “buyers” are typically the people who can sponsor, purchase, specify, pilot, or commercially engage across diagnostics, interventional cardiology tools, imaging ecosystems, digital health, clinical education, guideline implementations, and research/real-world evidence programs.
Main attendee groups we would expect (buyer-relevant)
- Interventional and clinical cardiology specialists (influencers for devices/procedures; they also shape clinical requirements)
- Cardiology department leadership (heads of cardiology, service line directors, clinical directors who influence budgets and vendor selection)
- Imaging specialists (Echocardiography/cardiac imaging and modalities that drive equipment and software needs)
- Electrophysiology / rhythm specialists (device- and workflow-driven buyer profiles)
- Hospital procurement & supply chain stakeholders (direct budget owners for devices and equipment)
- Clinical research leaders (clinical trials, observational studies, registries, scientific collaborations)
- Digital health / data / AI stakeholders in healthcare (responsible AI and digital health themes are highlighted on the ESC site excerpt)
- Industry medical affairs & HEOR / outcomes teams (they help decide go-to-market focus, evidence needs, and engagement strategy)
- Education / training stakeholders (CME, curriculum, clinical education innovation)
Where buyer intent usually concentrates
In cardiology congresses of this type, buyer engagement tends to concentrate around:
- New technology launches and clinical evidence updates (device, imaging, diagnostics)
- Guideline-linked workflows and implementation pathways
- AI-enabled clinical workflows (decision support, imaging analysis, risk stratification)
- Real-world data and outcomes discussions (HEOR, registries, post-market studies)
2) Where the show is happening + attendee geographic origin
The provided excerpt explicitly indicates Munich. The venue name and full on-site geographic description (e.g., whether it is at a named congress center) are not included in the excerpt we received.
Location
- City: Munich
- Country: Germany (Munich)
- Venue name: not available in the provided excerpt
Attendee geographic origin (buyer-relevant expectations)
Because ESC is European and positions its congress as a global cardiology meeting, we would generally expect a strong mix of:
- Europe-wide attendees (EU + UK + Switzerland + other European cardiology communities)
- International participation (especially companies with European commercial operations and global research footprints)
Note: Exact attendee origin percentages/countries are not present in the provided text, so we are not asserting specific numbers.
3) Audience reach (Local / National / Global)
Based on the description “World’s Foremost Cardiology Meeting” and the ESC positioning as a major international cardiology organization, we rate the reach as global with a European core.
- Local: present (Munich/Germany-based clinicians and organizations)
- National: strong Germany representation
- Global: high likelihood, driven by international industry participation and global cardiology relevance
4) Sample buyer company names (BUYERS ONLY) + Websites
Below is a curated set of cardiology-industry buyer targets that typically show up at major cardiovascular congresses—especially for devices, diagnostics, imaging, digital health, and evidence-led clinical engagement. These are buyer-oriented accounts (or organizations with clear buying/specifying/procurement relevance).
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Medtronic | https://www.medtronic.com | Director, Interventional Cardiology Marketing / Product Strategy; VP, Clinical Affairs (Cardiovascular) | Large cardiovascular portfolio with strong focus on clinical evidence, imaging/workflow integration, and post-market evidence needs at major cardiology meetings. |
| 2 | Abbott | https://www.abbott.com | Senior Manager, Structural Heart / CRM & Clinical Education; Director, Medical Affairs (Cardiology) | Structural heart and diagnostics presence aligns tightly with cardiology congress education, device adoption, and physician engagement. |
| 3 | Boston Scientific | https://www.bostonscientific.com | EMEA Business Unit Director, Cardiology; Clinical Affairs Director (Interventional) | Interventional cardiology solutions rely on evidence-led engagement, congress sponsorship, and clinical training initiatives. |
| 4 | Edwards Lifesciences | https://www.edwards.com | Director, European Market Access & Clinical Evidence; VP, Structural Heart Clinical Affairs | Structural heart leadership teams often prioritize major ESC-style congresses for clinical dissemination and evidence alignment. |
| 5 | Siemens Healthineers | https://www.siemens-healthineers.com | Director, Cardiology Imaging & AI Solutions; Product Marketing Manager, Cardiac Imaging | The congress messaging includes AI’s role in cardiology, which directly matches imaging AI and workflow optimization buyers. |
| 6 | Philips | https://www.philips.com | Director, Cardiac Imaging Systems; VP, Digital Health Partnerships (EMEA) | Imaging and digital health ecosystems are commonly represented, especially when AI and clinical workflow transformation are central themes. |
| 7 | GE HealthCare | https://www.gehealthcare.com | Director, Cardiovascular Imaging; Product Manager, Ultrasound/CT/MR Cardiac Applications | Cardiac imaging and clinical workflow buyers align with congress learning sessions, demonstrations, and cross-modality evidence. |
| 8 | Roche Diagnostics | https://diagnostics.roche.com | European Marketing Lead, Cardio-Metabolic Diagnostics; Director, Clinical Evidence & HEOR | Cardiovascular diagnostics and evidence-led adoption strategies fit cardiology congress engagement patterns. |
| 9 | Novartis | https://www.novartis.com | Director, Cardiovascular Medical Affairs; Head, Real-World Evidence (Cardio) | Major pharma with cardiovascular programs commonly participates through evidence, outcomes, and clinical education participation. |
| 10 | AstraZeneca | https://www.astrazeneca.com | Medical Affairs Director (Cardiovascular); Senior Manager, Evidence Generation & Outcomes | AstraZeneca’s cardiology focus pairs naturally with ESC’s scientific agenda and real-world evidence discussions. |
| 11 | Bayer | https://www.bayer.com | Head of Cardiovascular Portfolio Strategy; Director, Clinical Research (Cardio) | Cardiovascular portfolio strategy and clinical research teams are classic buyers for evidence and clinical engagement at ESC-style congresses. |
| 12 | Sanofi | https://www.sanofi.com | Director, Cardiovascular Medical Affairs; HEOR Lead, Cardiovascular | Works on cardiometabolic and cardiovascular outcomes themes that match congress education and outcomes conversations. |
| 13 | Daiichi Sankyo | https://www.daiichisankyo.com | EMEA Medical Affairs Director (Cardiovascular); Director, Clinical Evidence Strategy | Medical affairs and evidence teams often use major congress platforms for scientific and clinical engagement. |
| 14 | Boehringer Ingelheim | https://www.boehringer-ingelheim.com | Director, Cardiovascular Medical Affairs; Head, Real-World Evidence (Cardio) | Cardiovascular medical affairs and RWE strategy strongly match congress themes around evidence and AI-enabled clinical improvement. |
| 15 | Thermo Fisher Scientific | https://www.thermofisher.com | Director, Clinical Research Services (EMEA); Key Account Manager, Clinical Lab Diagnostics | Supports clinical research workflows and diagnostics ecosystems that are relevant to cardiology evidence generation. |
| 16 | Medline | https://www.medline.com | EMEA Director, Hospital Partnerships (Cardiology/Procedure); Procurement Strategy Manager | Procedure-related hospital supply and partner programs can intersect with cardiology departments’ buying cycles. |
| 17 | Terumo | https://www.terumo.com | Director, Interventional Cardiology Marketing; Clinical Affairs Manager (Cardio) | Interventional device ecosystems align with cardiology congress engagement and clinical education. |
| 18 | Cardinal Health | https://www.cardinalhealth.com | Director, Specialty Solutions (Cardiology); VP, Provider Partnerships (EMEA) | Provider partnership teams can be high-value buyers for hospital workflow-related solutions connected to procedure environments. |
| 19 | Siemens Energy / data-adjacent (AI ecosystem partners) | https://www.siemens.com | Director, Digital Industries Healthcare/AI Partnerships (if present); Enterprise AI Partnerships Lead | Only suitable if we are selling digital/AI or clinical AI infrastructure; the congress AI angle can attract cross-industry AI/solutions teams. |
| 20 | Amgen | https://www.amgen.com | Medical Affairs Director, Cardiovascular/Outcomes; RWE Strategy Manager | Outcomes and evidence generation teams align with evidence-centric cardiology congress content and engagements. |
Top “first outreach” set: Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, Siemens Healthineers. These cover the strongest cross-section of device + imaging + clinical evidence + AI-aligned themes.
5) Job profiles, industries & event type
Event type (buyer-relevant)
- Medical congress / scientific meeting
- Cardiology education & CME-style sessions (hands-on learning is referenced)
- Industry exhibition & clinical demonstrations (typical for major cardiology meetings)
- AI & digital health theme track (explicitly mentioned in the excerpt)
Job profiles we should target (high buyer relevance)
- Clinical leadership: Director of Cardiology, Head of Department (Cardiology), Clinical Director
- Imaging leadership: Director of Cardiac Imaging, Head of Echocardiography Lab, Imaging Modality Lead
- Interventional leadership: Director of Structural Heart Program, Lead for Cath Lab Operations
- Medical affairs & evidence: Medical Affairs Director, Clinical Evidence Manager, HEOR/Evidence Generation Lead
- Digital/AI stakeholders: Director, Digital Health, AI Product Lead, Responsible AI/Clinical Data Lead (if role exists)
- Procurement & operations: Procurement Manager (Medical Devices), Supply Chain Director (Hospitals), Value Analysis Manager
- Partnerships: Partnerships Director, Strategic Alliances Manager (hospital networks, academic and industry collaborations)
- Research leaders: Clinical Research Director, Trial Operations Lead, Registry Program Manager
Industries (from your provided industry list — suggested filters)
For ESC Congress buyer targeting, we would recommend prioritizing these industry filters from your list:
- Hospital & Health Care
- Medical Devices
- Pharmaceuticals
- Biotechnology
- Computer Software (for AI/digital health platforms)
- Information Technology & Services (for healthcare data platforms)
- Research (academic + clinical research organizations)
- Market Research (HEOR, outcomes research, evidence services)
- Events Services (conference sponsors/production partners—only if relevant to your offering)
6) Estimated attendance (expected total footfall)
The provided excerpt does not include an attendance figure. Therefore, we cannot reliably state an estimated total footfall from the text we received. Attendance: not available in provided text
If you want, we can refine this once you provide either: (a) the ESC Congress 2026 attendance/registration statement from your source, or (b) the specific venue/congress center page content that typically includes capacity and participant counts.
7) Key focus areas & buyer engagement
The provided official meta description highlights: AI’s role in cardiology, hands-on learning, and transformative discussions plus global expert connections.
Key focus areas that strongly map to buyer needs
- AI in cardiology: decision support, imaging analytics, workflow automation, responsible AI in clinical settings
- Education & skills transfer: hands-on sessions and practical guidance that drive product adoption and training demand
- Evidence generation & translation: turning research findings into clinical practice improvements
- Technology-enabled care pathways: imaging, interventional tools, and digital platforms supporting diagnosis and treatment
- Global clinical dialogue: standardization of best practices across international communities
Buyer engagement angles that we would use
- Clinical evidence & implementation: connect our approach to outcomes, adoption readiness, and guideline-linked execution
- AI & responsible digital health alignment: position deliverables around governance, auditability, and clinical validation
- Operational fit: focus on reducing time-to-diagnosis, improving workflow efficiency, and strengthening procedure readiness
- Training and education hooks: demonstrate how we support hands-on learning, credentialing, or education program rollouts
8) Client-product fit review (required input)
We can identify the best buyer segments for attendee-list targeting based on the exact product we are selling. To do that correctly, please share the client’s website URL (and, ideally, a 2–3 line description of what the product does).
What we need from you
- Client website: please provide the exact URL
- Product category: e.g., AI imaging software, medical device, diagnostic kit, education/CME platform, recruiting/staffing, analytics/RWE, etc.
- Primary buyer type: hospitals, pharma/medtech, academic centers, procurement, or digital health organizations
- Target region: EU-wide, Germany-first, or global
Provisional best buyer matches (while waiting for client website)
Until we receive the client website, we can only provide a best-guess buyer shortlist aligned to the event’s AI-in-cardiology theme and typical ESC congress participation:
- Imaging AI / digital health vendors → Siemens Healthineers, Philips, GE HealthCare (digital imaging teams)
- Medical device companies → Medtronic, Abbott, Boston Scientific, Edwards Lifesciences
- Clinical evidence / RWE-oriented organizations → Roche Diagnostics, major pharma (Novartis/AstraZeneca/Bayer/Boehringer/Ingelheim)
- Procurement-facing hospital stakeholders → hospital procurement directors and value-analysis leaders (filter by Hospital & Health Care)
Once we review the client website, we will deliver a ranked buyer list (company + job titles) and match them precisely to the product’s purchasing center.
9) Final recommendation (how we would position this event for research + buyer extraction)
ESC Congress 2026 (Munich) is a strong event for deep cardio-industry buyer research and targeted buyer extraction because:
- It is positioned as a world-leading cardiology meeting (dense concentration of specialized buyers and clinical influencers)
- It explicitly spotlights AI’s role in cardiology (excellent for AI/digital health, imaging analytics, and responsible tech stakeholders)
- It combines education/learning and global expert discussion (ideal for solutions that require clinical buy-in and evidence alignment)
- It is expected to attract both hospital decision-makers and industry evidence/medical affairs leadership
Next step: send the client website URL so we can refine and produce the “best buyers for your requirement” shortlist with accurate title targeting.
Data sheet
| Event Name | ESC Congress - European Society of Cardiology |
| Event Date | 2026-08-28 to 2026-08-31 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the provided official page text |
| City | Munich |
| State / Region | Bavaria |
| Country | Germany |
| Organizer | European Society of Cardiology (ESC) |
| Official Event Website | escardio.org/events/congresses/esc-congress/ |
| Event Type | International medical congress / scientific conference / professional education event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Business Services; IT & Technology |
| Audience Reach | Global cardiology audience |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for current edition; official page confirms event and city, but not a public attendance count in the provided text. |
| Main Purpose of Event | To convene global cardiovascular professionals for scientific exchange, education, clinical updates, innovation, and networking around cardiology and related health technologies. |
ESC Congress is the flagship annual meeting of the European Society of Cardiology and is positioned as one of the world’s foremost cardiology congresses. The official event page highlights Munich as the 2026 host city and emphasizes AI’s role in cardiology, hands-on learning, and transformative discussions, indicating a strong focus on clinical innovation and evidence-based practice.
The congress is highly relevant to clinicians, researchers, hospital leaders, medtech and pharma stakeholders, digital health providers, and public health organizations. For B2B outreach, it offers strong opportunities to engage decision-makers involved in diagnostics, cardiovascular devices, therapeutics, health data, clinical education, and digital transformation in healthcare.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Hospital / Health System Leadership | Hospitals, cardiac centers, academic medical centers, health networks | Clinical buying influence, service selection, technology adoption | High-value for diagnostics, imaging, digital health, monitoring, and care pathway solutions |
| Cardiologists and Specialist Physicians | Private practices, hospitals, group practices, academic departments | Clinical opinion leaders, product champions, protocol influencers | Strong for therapeutics, devices, imaging, and clinical software |
| Procurement and Sourcing Teams | Hospital procurement, group purchasing, healthcare supply chains | Contracting, vendor selection, purchasing approval | Relevant for equipment, consumables, IT, and service contracts |
| Medical Device Buyers | Cath labs, cardiology departments, operating suites, distributors | Product evaluation, device selection, procurement influence | Direct relevance for interventional, monitoring, imaging, and implantable solutions |
| Pharma / Biotech Decision-Makers | Cardiovascular drug manufacturers, biotech firms, life sciences groups | R&D collaboration, evidence generation, brand and scientific partnerships | Useful for clinical research, real-world evidence, congress services, and data solutions |
| Health IT / Digital Health Leaders | Digital health vendors, hospital IT, EHR and analytics teams | Technology selection, integration, AI and workflow adoption | High relevance given the official focus on AI in cardiology |
| Researchers and Trial Leaders | Universities, clinical research centers, trial networks | Study design, research procurement, partnerships | Relevant for CROs, data platforms, registries, and research tools |
| Public Health / Policy Leaders | Health ministries, public health institutions, professional bodies | Guideline influence, policy direction, system-level adoption | Relevant for population health, prevention, and health-system vendors |
| Distributors and Channel Partners | Medtech distributors, regional agents, specialty wholesalers | Market access, commercial expansion, portfolio sourcing | Useful for suppliers seeking European cardiology channel coverage |
| Association and Society Leaders | National cardiac societies, professional associations, councils | Partnerships, educational programs, sponsorship decisions | Relevant for congress services, education, and advocacy partnerships |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host City | Munich and surrounding metro area | Medium | Strong local academic and hospital presence supports attendance |
| Host Region | Bavaria and wider southern Germany | High | Accessible to major hospitals, universities, and medtech firms |
| Nearby Business Hubs | Munich, Stuttgart, Frankfurt, Zurich, Vienna | High | Medical device, pharma, and health-tech buyer density is strong in Central Europe |
| National Reach | Germany-wide medical, scientific, and procurement audiences | High | ESC congresses typically draw broad national participation |
| International Reach | Europe, UK, Middle East, North America, Asia-Pacific | Very High | Official positioning indicates a global cardiology meeting |
| Trade / Collaboration Corridors | EU cardiology, medtech, pharma, clinical research, digital health | High | Relevant for suppliers seeking European healthcare decision-makers |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The ESC brand, cardiology focus, and official congress positioning indicate a worldwide professional audience. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Abbott | Medical devices / diagnostics buyer-side organization | Major cardiovascular portfolio and strong relevance to clinical and device innovation discussions | abbott.com | VP Clinical Affairs, Director of Marketing, Product Manager, Medical Affairs Director | Strong Market Fit, Attendance Not Confirmed |
| Medtronic | Medical technology buyer-side organization | Cardiovascular devices, electrophysiology, and hospital-focused solutions align closely with congress content | medtronic.com | Global Product Director, Strategic Marketing Director, Clinical Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
| Boston Scientific | Cardiovascular medtech buyer-side organization | Interventional and rhythm-management relevance makes this a high-value account | bostonscientific.com | Business Development Director, Regional Marketing Manager, Medical Affairs Director | Strong Market Fit, Attendance Not Confirmed |
| Edwards Lifesciences | Structural heart / medtech buyer-side organization | Structural heart and valve therapy discussions fit the conference’s clinical audience | edwards.com | Director of Clinical Education, Product Marketing Manager, Therapy Development Specialist | Strong Market Fit, Attendance Not Confirmed |
| Siemens Healthineers | Imaging / diagnostics buyer-side organization | Cardiac imaging, diagnostics, and AI-enabled workflows align with the event theme | siemens-healthineers.com | Clinical Applications Manager, AI Product Lead, Head of Cardiovascular Solutions | Strong Market Fit, Attendance Not Confirmed |
| Philips | Health technology buyer-side organization | Cardiology monitoring, imaging, and digital health offerings fit a cardiology congress audience | philips.com | Global Category Manager, Product Director, Clinical Strategy Director | Strong Market Fit, Attendance Not Confirmed |
| GE HealthCare | Imaging and diagnostics buyer-side organization | Cardiac imaging, ultrasound, and AI tools are highly relevant to ESC attendees | gehealthcare.com | VP Product, Clinical Marketing Director, Solutions Manager | Strong Market Fit, Attendance Not Confirmed |
| Bayer | Pharma / life sciences buyer-side organization | Cardiovascular therapeutics and scientific exchange are central to the audience profile | bayer.com | Medical Director, Brand Lead, Market Access Manager | Strong Market Fit, Attendance Not Confirmed |
| Boehringer Ingelheim | Pharma / life sciences buyer-side organization | Cardio-metabolic and cardiovascular therapeutic stakeholders are likely attendees or partners | boehringer-ingelheim.com | Medical Affairs Lead, Director Clinical Research, Portfolio Manager | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharma / biotech buyer-side organization | Large cardiovascular portfolio and strong scientific congress presence potential | novartis.com | Global Medical Affairs, Franchise Director, Scientific Communications Lead | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharma / life sciences buyer-side organization | Cardiovascular, renal, and metabolic intersection makes it relevant to ESC audiences | astrazeneca.com | Medical Affairs Director, Brand Strategy Lead, Field Medical Lead | Strong Market Fit, Attendance Not Confirmed |
| Roche | Diagnostics / pharma buyer-side organization | Diagnostics, data, and disease management themes fit the congress audience | roche.com | Product Director, Head of Medical Affairs, Diagnostics Marketing Lead | Strong Market Fit, Attendance Not Confirmed |
| University Hospital Network / Academic Medical Centers | Institutional healthcare buyers | Large clinical audiences, research procurement, and technology adoption teams are typical attendees | example: ukr.de | Head of Cardiology, Procurement Director, Research Manager, Digital Health Lead | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Chief Clinical Officer | Executive / Clinical Leadership | C-Level | Influences hospital-wide clinical priorities and technology adoption. |
| 2 | Director of Cardiology / Head of Cardiology | Clinical Services | Director / Senior Director | Key influencer for procedure, device, and treatment pathway decisions. |
| 3 | Chief Information Officer / IT Director | Information Technology | C-Level / Director | Important for AI, interoperability, imaging, and digital workflow solutions. |
| 4 | Procurement Director / Strategic Sourcing Manager | Procurement / Supply Chain | Director / Manager | Owns purchasing, vendor onboarding, and contract negotiations. |
| 5 | Medical Affairs Director / Scientific Communications Lead | Medical Affairs | Director / Senior Manager | Critical for congress sponsorships, clinical content, and evidence-based engagement. |
| 6 | Product Manager / Marketing Manager | Marketing / Product | Manager / Senior Manager | Drives launch planning, field education, and scientific positioning. |
| 7 | Clinical Research Director / Trial Manager | Clinical Research | Director / Manager | Relevant for data platforms, registries, and research partnerships. |
| 8 | Digital Health Lead / AI Product Lead | Innovation / Digital Health | Manager / Director | High relevance due to the congress focus on AI in cardiology. |
| 9 | Hospital Operations Director / Facility Director | Operations / Facilities | Director | Influences equipment planning, service contracts, and clinical capacity. |
| 10 | Partnerships Director / Business Development Director | Commercial / Partnerships | Director | Best for sponsorships, distribution, licensing, and alliance opportunities. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core audience and primary buyer environment for cardiology solutions. | Hospitals, cardiac centers, health systems, and care delivery networks. |
| 2 | Medical Devices | Directly aligned with interventional, monitoring, and cardiovascular device buyers. | Device manufacturers, distributors, and hospital device evaluation teams. |
| 3 | Pharmaceuticals | Relevant for cardio-metabolic and cardiovascular drug stakeholders. | Medical affairs, market access, and scientific communications outreach. |
| 4 | Biotechnology | Strong for biomarker, therapy, and clinical research partnerships. | R&D, translational medicine, and evidence-generation teams. |
| 5 | Information Technology & Services | Supports AI, analytics, interoperability, and digital workflow buyers. | Digital health, analytics, and clinical software engagement. |
| 6 | Research | ESC congress is science-driven and research-heavy. | Clinical trial networks, registries, and research technology platforms. |
| 7 | Medical Practice | Includes physician buyers and practice-level clinical decision-makers. | Specialist physician outreach and continuing education campaigns. |
| 8 | Government Administration | Public health and policy stakeholders can shape population-level care. | Health ministries, policy teams, and public-sector programs. |
| 9 | Logistics & Supply Chain | Relevant for medical supply distribution and procurement operations. | Supply chain, distribution, and inventory management solutions. |
| 10 | Management Consulting | Advisory firms often support healthcare transformation and market access. | Healthcare strategy, commercialization, and innovation consulting. |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Organizer official page provided in source text | No attendance number was present in the supplied official content. |
| Exhibitor count | Not publicly confirmed | Confirmed unavailable | Official event page text supplied | No exhibitor count was provided in the source text. |
| Buyer count | Not publicly confirmed | Confirmed unavailable | Official event page text supplied | Buyer-side count not disclosed by organizer in the provided text. |
| Speaker count | Not publicly confirmed | Confirmed unavailable | Official event page text supplied | No speaker count was provided in the source text. |
| Sponsor count | Not publicly confirmed | Confirmed unavailable | Official event page text supplied | No sponsor count was provided in the source text. |
| Historical attendance | Not included | Not used | No prior-year official figure supplied in source text | Historical attendance should be added only from an official prior-year source if needed. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical education | Hands-on learning and guideline updates | Workshops, demonstrations, and evidence-led sessions | Education platforms, congress services, training content |
| AI in cardiology | Clinical decision support and workflow optimization | High-interest topic for demos and executive conversations | AI software, analytics, imaging algorithms, data tools |
| Cardiovascular devices | Improved outcomes, procedural efficiency, reliability | Product comparisons, clinician engagement, KOL visibility | Interventional devices, monitoring, imaging, implants |
| Pharma and therapeutics | Scientific credibility and market access | Medical affairs networking and research collaboration | Clinical trial support, communications, evidence services |
| Digital health | Remote monitoring and interoperable care delivery | IT and clinical innovation buyer conversations | Software, platforms, patient engagement, remote care tools |
| Research and evidence generation | Registry access, study data, and publication support | Research partnerships, data sharing, sponsorships | CRO services, RWE platforms, analytics, databases |
| Public health and prevention | Population-level cardiovascular risk reduction | Policy engagement and institutional partnership discussions | Health policy, analytics, screening, prevention programs |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event attracts clinicians, hospitals, pharma, medtech, and health-tech stakeholders with active purchasing influence. |
| Decision-maker availability | High | Strong concentration of directors, heads, and senior medical leaders is likely. |
| Data collection potential | Medium | Useful public data exists for organizer and topic positioning, but current attendee lists were not supplied. |
| Apollo targeting potential | Very High | Excellent fit for healthcare, medical device, pharma, research, and digital health targeting. |
| Geographic targeting potential | High | Munich and Europe are strong anchors, while global cardiology participation broadens reach. |
| Best outreach approach | High-touch, account-based outreach | Target senior clinical, medical affairs, procurement, and innovation leaders with evidence-led messaging. |
| Overall lead quality | Very High | One of the strongest cardiology-based B2B audiences for healthcare, device, pharma, and digital health suppliers. |
| Best use case | Attendee list building, account targeting, sponsorship prospecting, and clinical buyer outreach | Best suited for sales teams focused on healthcare decision-makers and professional education ecosystems. |
| Limitations / risks | No confirmed current-year attendee list in the provided source text | Avoid claiming attendance for any company without official confirmation. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Information Technology & Services; Research; Government Administration; Management Consulting; Logistics & Supply Chain; Medical Practice | Focus on organizations most likely to buy, influence, sponsor, or collaborate at ESC Congress. |
| Departments | Clinical; Medical Affairs; Research; Procurement; Purchasing; Product; Marketing; Business Development; Innovation; IT | Reach both clinical decision-makers and commercial buyers. |
| Seniority | Manager; Director; VP; CXO; Partner; Head | Prioritize decision-makers and senior influencers. |
| Job titles | Head of Cardiology, CMO, Chief Clinical Officer, Procurement Director, Medical Affairs Director, Clinical Affairs Director, Product Manager, VP Marketing, Digital Health Lead, Research Director | Captures the most likely event buyers and influencers. |
| Geography | Germany; DACH; EU; UK; Switzerland; Benelux; Nordics; United States | Aligns with Munich hosting and the congress’s international reach. |
| Employee size | 200-500; 500-1,000; 1,000-5,000; 5,000-10,000; 10,000+ | Covers large hospital systems, medtech firms, and pharma companies. |
| Keywords | cardiology OR cardiovascular OR heart OR structural heart OR electrophysiology OR imaging OR digital health OR AI OR medical affairs OR clinical research | Improves precision for event-specific buyer capture. |
| Company type | Public company; privately held; hospital network; academic medical center; government / public sector | Covers the broad set of likely attendees and buyers. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| European Society of Cardiology – ESC Congress official page | Official organizer website | Event name, 2026 Munich location, and congress positioning as the world’s foremost cardiology meeting | High |
| European Society of Cardiology homepage | Official organizer website | Organizer identity, mission, and educational/congress portfolio | High |
| Provided official website text excerpt | Primary source excerpt | Confirmed the 2026 Munich edition and the AI-in-cardiology thematic emphasis | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to ESC Congress - European Society of Cardiology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.